The interplay between genetic and lifestyle obesity-related risk factors could be an important reason for the increasing epidemic of diabetes mellitus

• by Salah Gariballa, Ghada S. M. Al-Bluwi, Javed Yasin

• June 19, 2026

Magnetic vs stapled technique in jejuno-ileal bipartition: one-year outcomes

• by Martin Fried, D. Michalsky, J. N. Buchwald, D. Charpentier, J. Schneider, Michel Gagner

• June 15, 2026

Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial

• by Richard E. Pratley, Douglas Scott Denham, Rupal Trivedi, Elaine Watkins, Lisa Connery, Jennifer Barnes, Dongzi Yu, Janet Hong, Christopher Simard, Kimberly Umans, Lan Liu, Giridhar S. Tirucherai, Jing L. Marantz

• June 8, 2026

Combo Therapy May Improve HbA1c in Type 2 Diabetes

Oral orforglipron could be more effective in reducing hemoglobin A1c and body weight, with no increased risk of hypoglycemia in patients with inadequately controlled type 2 diabetes.

• by Andrea Surnit

• June 12, 2026

• 4 min